Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population
ConclusionIn patients with high atherosclerotic cardiovascular risk, taking beta-blockers had a higher risk of 3P-MACEs. Care should be taken when prescribing beta-blockers to patients without a clear indication.Trial registrationTCTR20130520001 registered in Thai Clinical Trials Registry (TCTR)https://www.thaiclinicaltrials.org/, date of registration 20 May 2013.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Beta-Blockers | Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Attack | Stroke | Study | Thailand Health